UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 5
May-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2405617


Registration ID:
540283

Page Number

g115-g128

Share This Article


Jetir RMS

Title

A comprehensive analysis of the utilization of chitosan-based nanoparticles loaded with Vancomycin for the purpose of targeted medication delivery in the treatment of Colitis

Abstract

The project aimed to produce particle formulations based on chitosan (CH) for the transport of vancomycin (VM) to the colon. Different technological procedures were used to prepare chitosan nanoparticles (NPs) loaded with VM. With significant physicochemical and biological characteristics like biocompatibility, biodegradability, nontoxicity, non-immunogenicity, bio adhesion, and antibacterial, antifungal, and hemostatic action, chitosan is a linear polysaccharide. Because of its unique chemical structure, chitosan can be modified in certain ways. It also works well as a drug nanocarrier when chitosan particles are smaller than nanoscale. In this work, tripolyphosphate (TPP) was used as a cross-linker to facilitate the ionotropic gelation process that produced chitosan nanoparticles (CSNPs). The outcomes verified that vancomycin was effectively loaded onto chitosan nanoparticles. Moreover, it has been noted that 40% of the vancomycin is released in bursts during the first nine hours, and that the medication is then slowly released until 90% is released at the hundred-hour.

Key Words

Drug release, Vancomycin, Chitosan nanoparticles, Cross-linker, Polysaccharide

Cite This Article

"A comprehensive analysis of the utilization of chitosan-based nanoparticles loaded with Vancomycin for the purpose of targeted medication delivery in the treatment of Colitis", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 5, page no.g115-g128, May-2024, Available :http://www.jetir.org/papers/JETIR2405617.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A comprehensive analysis of the utilization of chitosan-based nanoparticles loaded with Vancomycin for the purpose of targeted medication delivery in the treatment of Colitis", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 5, page no. ppg115-g128, May-2024, Available at : http://www.jetir.org/papers/JETIR2405617.pdf

Publication Details

Published Paper ID: JETIR2405617
Registration ID: 540283
Published In: Volume 11 | Issue 5 | Year May-2024
DOI (Digital Object Identifier):
Page No: g115-g128
Country: Purba Bardhaman, West Bengal, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00014

Print This Page

Current Call For Paper

Jetir RMS